These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 101627)

  • 1. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on bacteriocin (marcescin) typing of Serratia marcescens. I. Fundamental studies on bacteriocin (marcescin) production and sensitivity (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1977 Sep; 51(9):487-98. PubMed ID: 416153
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serratia marcescens infection in intensive care units (author's transl)].
    Freitag V; Morr-Strathmann U; Caselitz FH; Lawin P
    Prakt Anaesth; 1975 Jun; 10(3):119-25. PubMed ID: 787963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued epidemiological surveillance of Serratia marcescens infections by bacteriocin typing, with particular reference to strains isolated at Erlangen.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1974; 229(3):372-82. PubMed ID: 4155886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
    Yama H; Yamada K; Tsujimoto T
    Jpn J Antibiot; 1979 Jun; 32(6):661-7. PubMed ID: 381707
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of clinical isolates of Serratia marcescens by bacteriocin typing: a comparison of bacteriocin types between two distant university hospitals].
    Nasu M; Goto J; Goto Y; Tashiro T; Itoga T; Yamaguchi K
    Kansenshogaku Zasshi; 1984 Apr; 58(4):312-7. PubMed ID: 6434655
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracellular organisation of bacteriophage tail-like bacteriocins of group A in Serratia marcescens (author's transl)].
    Acker G
    Arch Microbiol; 1976 Dec; 111(1-2):175-83. PubMed ID: 797334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.